DOTA-EB-TATE

DOTA-EB-TATE is a peptide-drug conjugate combining a somatostatin analog with an Evans Blue derivative, designed to improve pharmacokinetics and reduce toxicity for peptide receptor radionuclide therapy (PRRT) research. It serves as a versatile precursor for developing radiopharmaceutical conjugates, applicable in both in vitro binding assays and in vivo preclinical tumor targeting studies.